Patients' adherence to anti-diabetic medications in a Hospital at Ajman, UAE

Malaysian Journal of Medical Sciences

Volumn 21, Issue 1, 2014, Pages 44-49

  Arifulla, Mohammed ^a   John, Lisha Jenny ^a   Sreedharan, Jayadevan ^a   Muttappallymyalil, Jayakumary ^a   Basha, Sheikh Altaf ^a  

^a GULF MEDICAL UNIVERSITY   (United Arab Emirates)

Author keywords

Anti diabetic drugs; Compliance; Diabetes mellitus; Patient adherence; Patient physician relationship

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE DERIVATIVE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; FEEDING BEHAVIOR; FEMALE; FINANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICATION COMPLIANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; QUESTIONNAIRE; SELF MEDICATION; SELF REPORT; TREATMENT REFUSAL; UNITED ARAB EMIRATES;

EID: 84902478255     PISSN: 1394195X     EISSN: 21804303     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. World Health Organization. Diabetes programme: Country and Regional Data [Internet]. Geneva (CH): World Health Organization; 2009 (cited 2013 Jul 20). Available from: http://www. who. int/diabetes/facts/world_figures/en/.
2. Kuo YF, Raji MA, Markides KS, Ray LA, Espino DV, Goodwin JS. Inconsistent use of diabetes medications, diabetes complications, and mortality in older Mexican American over a 7-year period. Diabetes Care. 2003; 26(11): 3054-3060.
3. Malik M, Bakir A, Abi Saab B, King H. Glucose intolerance and associated factors in the multi-ethnic population of the United Arab Emirates: results of a national survey. Diabetes Res Clin Pract. 2005; 69(2): 188-195. doi: 10. 1016/j. diabres. 2004. 12. 005.
4. World Health Organization. Adherence to Long-Term Therapies. Evidence for action. Geneva(CH): World Health Organization; 2003.
5. Lau DT, Nau DP. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care. 2004; 27(9): 2149-2153.
6. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005; 43(6): 521-530.
7. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006; 333(7557): 15.
8. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006; 166(17): 1836-1841.
9. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008; 359(15): 1577-1589.
10. Pladevall M, Williams LK, Potts LA, Divine G, Xi H, Lafata JE. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care. 2004; 27(12): 2800-2805.
11. Hansen RA, Kim MM, Song L, Tu W, Wu J, Murray MD. Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother. 2009; 43(3): 413-422. doi: 10. 1345/aph. 1L496.
12. Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care. 2003; 26(5): 1408-1412.
13. Donnan PT, MacDonald TM, Morris AD. Adherence to prescribed oral hypoglycemic medication in a population of patients with type 2 diabetes: a retrospective cohort study. Diabet Med. 2002; 19(4): 279-284.
14. Gimenes HT, Zanetti ML, Haas VJ. Factors related to patient adherence to antidiabetic drug therapy. Rev Latinoam Enfermagem. 2009; 17(1): 46-51.
15. Tiv M, Viel J-F, Mauny F, Eschwège E, Weill A, Fournier C, et al. Medication Adherence in Type 2 Diabetes: The ENTRED Study 2007, a French Population-Based Study. PLoS One. 2012; 7(3): e32412. doi: 10. 1371/journal. pone. 0032412.
16. Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an Indigent population. Diabetes Care. 2002; 25(6): 1015-1021.
17. Adisa R, Alutundu MB, Fakeye TO. Factors contributing to nonadherence to oral hypoglycemic medications among ambulatory type 2 diabetes patients in Southwestern Nigeria. Pharmacy Practice (Internet). 2009; 7(3): 163-169. doi: 10. 4321/S1886-36552009000300006.
18. Jayant D, Lawrence B, Richard G. Factor Influencing Patient Acceptability of Diabetes Treatment Regimens. Clinical Diabetes. 2000; 18(2).
19. Schroeder K, Fahey T, Ebrahim S. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Syst Rev. 2004; 2: CD004804.
20. Ohene Buabeng K, Motowel L, Plange-Rhule J. Unaffordable drug prices: the major cause of noncompliance with hypertensive medication in Ghana. J Pharm Sci. 2004; 7(3): 350-352.
21. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999; 47(6): 555-567.
22. Rubin RR. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Me. 2005; 118(5A Suppl): S27S-S34.